LEADER 04236nam  22007215  450 
001 9910254520703321
005 20200630084015.0
010   $a3-319-39504-1
024 7 $a10.1007/978-3-319-39504-3
035   $a(CKB)3710000000831514
035   $a(DE-He213)978-3-319-39504-3
035   $a(MiAaPQ)EBC4648914
035   $a(PPN)194805867
035   $a(EXLCZ)993710000000831514
100   $a20160818d2016      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHypertension and Metabolic Cardiovascular Risk Factors /$fby Arrigo F. G. Cicero
205   $a1st ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016.
215   $a1 online resource (XIII, 102 p. 31 illus., 13 illus. in color.) 
225 1 $aPractical Case Studies in Hypertension Management,$x2364-6632
311   $a3-319-39503-3 
320   $aIncludes bibliographical references at the end of each chapters.
327   $aClinical case 1: Adult Patient with Hypertension and Metabolic Syndrome -- Clinical case 2: Adult Patient with Hypertension and Diabetes -- Clinical case 3: Adult Patient with Hypertension and Familial Hypercholesterolemia -- Clinical case 4: Adult Patient with Hypertension and Hypertriglyceridemia -- Clinical case 5: Adult Patient with Hypertension and Obesity -- Clinical case 6: Adult Patient with Hypertension and Gout.
330   $aThe aim of this guide is to provide clinicians with practical reference for the management of hypertensive patients with other cardiovascular risk factors, which originate from impaired metabolic functions. With the aid of carefully selected, paradigmatic case studies, the physician will find sound advice for the best approach to common but often under-recognized clinical situations, and answers to practical questions that arise when a specific condition is not directly addressed in the guidelines. Question-and-answer sections will help the reader to identify at a glance the most complex steps in the diagnostic and therapeutic process. In a ?real world? clinical setting, the hypertensive patient rarely presents with hypertension as the only cardiovascular risk factor, and is more likely to be affected by other metabolic risk factors, such as impairment of lipid metabolism, glucose homeostasis, and purine metabolism, and by overweight or obesity. These cases will serve as a basis for analyzing best practice, highlighting problems in diagnosis and treatment, and selecting the most appropriate management of patients with metabolic risk factors in everyday practice.
410  0$aPractical Case Studies in Hypertension Management,$x2364-6632
606   $aCardiology
606   $aEndocrinology 
606   $aMetabolic diseases
606   $aDiabetes
606   $aAngiology
606   $aNephrology
606   $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037
606   $aEndocrinology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33053
606   $aMetabolic Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33118
606   $aDiabetes$3https://scigraph.springernature.com/ontologies/product-market-codes/H33045
606   $aAngiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33010
606   $aNephrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33126
615  0$aCardiology.
615  0$aEndocrinology .
615  0$aMetabolic diseases.
615  0$aDiabetes.
615  0$aAngiology.
615  0$aNephrology.
615 14$aCardiology.
615 24$aEndocrinology.
615 24$aMetabolic Diseases.
615 24$aDiabetes.
615 24$aAngiology.
615 24$aNephrology.
676   $a616.1071
700   $aCicero$b Arrigo F. G$4aut$4http://id.loc.gov/vocabulary/relators/aut$0786998
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910254520703321
996   $aHypertension and Metabolic Cardiovascular Risk Factors$92508602
997   $aUNINA